Repligen Corporation (RGEN): Stock Guide for Investors

Key Information

Ticker Symbol: RGEN

Exchange: Nasdaq

Industry: Biotechnology

Real-Time Stock Quote

Click here for the latest real-time stock quote for Repligen Corporation (RGEN).

Stock Performance and History

• RGEN stock has had a strong performance over the past year, rising by over 100%.
• The company has a market capitalization of over $10 billion.
• RGEN's revenue has grown steadily in recent years, with a strong revenue growth rate of over 20% in the past year.

Financial Data and Analysis

Repligen Corporation's financial data and analysis can be found on websites such as Yahoo Finance and MarketWatch.

News and Insights

• RGEN has been in the news recently for its acquisition of Vybex Animal Health.
• Analysts are generally positive on RGEN stock, with a consensus recommendation of "buy".
• The company is expected to continue to perform well in the future, with a projected revenue growth rate of over 15% in the next year.

Conclusion

Repligen Corporation (RGEN) is a leading biotechnology company with a strong track record of growth and profitability. The company's stock has performed well over the past year and is expected to continue to perform well in the future.